AME vs PLX · P/E 30, rev $2.04B vs P/E 31, rev $53.6M
Ametek Inc (AME) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported PLX revenue for 2026-06-30 was $53.6M. Net income was $22.1M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
AME currently screens at market cap $42.11B and trailing P/E 29.9. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the AME and PLX stock pages for the full models.
Not investment advice.